Vertex reports second quarter 2023 financial results

Boston--(business wire)--vertex pharmaceuticals incorporated (nasdaq: vrtx) today reported consolidated financial results for the second quarter ended june 30, 2023 and updated its full year 2023 financial guidance. “the second quarter of 2023 marked another period of strong progress across our business. we are reaching more patients globally with our cystic fibrosis medicines, advancing our late-stage clinical programs and making rapid progress across our research and development pipeline of t.
VRTX Ratings Summary
VRTX Quant Ranking